Gaudium IVF and Women Health IPO
IPO Listing Details
- Listing Date
27 Feb 2026
- Listing Price
₹83.00
- Listing Change
5.06%
- Last Traded Price
₹133.41
Gaudium IVF and Women Health IPO Details
-
Open Date
20 Feb 2026
-
Close Date
24 Feb 2026
- IPO Price Range
₹ 75 to ₹79
- IPO Size
₹ 165 Cr
Gaudium IVF and Women Health IPO Timeline
Gaudium IVF and Women Health IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 20-Feb-2026 | 0.00 | 0.91 | 1.39 | 0.89 |
| 23-Feb-2026 | 0.02 | 4.63 | 4.03 | 3.01 |
| 24-Feb-2026 | 1.62 | 14.05 | 7.60 | 7.27 |
Last Updated: 03 July 2026 11:42 AM by 5paisa
Gaudium IVF and Women Health Limited delivers IVF treatments across India through a hub-and-spoke model, operating over thirty locations, including seven hubs and twenty-eight spokes. In strategic alliance with Infertility Experts, the company promotes awareness of ART and IVF. Centres are located in Delhi, Mumbai, Ludhiana, Srinagar, Patna and Bangalore. Services include IVF, ICSI, IUI, ovulation induction, male infertility treatments, PCOS care and high-risk pregnancy management for global patients worldwide.
Established in: 2015
Managing Director: Dr. Manika Khanna
Peers:
| Metric |
Gaudium IVF and Women Health Limited |
Inspire IVF Public Company Limited |
|
Face Value (₹ per share) |
5 | 0.05 |
| Total Revenue | 70.96 | 26.95 |
|
PAT |
19.13 | 5.51 |
| EPS (Basic) (₹) | 3.12 | 0.17 |
|
P/E Ratio |
- | 0.43 |
|
Return on Net Worth (RoNW) (%) |
41.71 | 3.97 |
| NAV | 7.54 | 4.34 |
Gaudium IVF and Women Health Objectives
1. The Company will fund new IVF centres (₹50.00 crore).
2. Repayment or prepayment of outstanding loans (₹20.00 crore).
3. Allocation towards general corporate purposes (₹70.00 crore total).
Gaudium IVF IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹165.00Cr |
| Offer For Sale | ₹75.00 Cr |
| Fresh Issue | ₹90.00 Cr |
Gaudium IVF IPO Lot Size
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 189 | 14,175 |
| Retail (Max) | 13 | 2,457 | 1,94,103 |
| S-HNI (Min) | 14 | 2, 646 | 1,98,450 |
| S-HNI (Max) | 66 | 12,474 | 9,85,446 |
| B-HNI (Min) | 67 | 12,663 | 9,49,725 |
Gaudium IVF IPO Reservation
| Investors Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB (Ex Anchor) | 1.62 | 41,77,240 | 67,85,478 | 53.61 |
| Non-Institutional Buyers | 14.05 | 31,32,930 | 4,40,22,069 | 347.77 |
| BNII | 12.71 | 20,88,620 | 2,65,55,634 | 209.79 |
| SNII | 16.73 | 10,44,310 | 1,74,66,435 | 137.98 |
| Individual Investors (IND category bidding for 2 Lots) | 7.60 | 73,10,170 | 5,55,42,942 | 438.79 |
| Total** | 7.27 | 1,46,20,340 | 10,63,50,489 | 840.17 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Revenue | 44.24 | 47.89 | 70.72 |
| EBITDA | 20.07 | 19.27 | 28.63 |
| PAT | 13.53 | 10.32 | 19.13 |
| Particulars (In ₹ Crores) | FY23 | FY24 | FY25 |
| Total Assets | 36.63 | 51.01 | 88.51 |
| Share Capital | 0.99 | 0.99 | 30.70 |
| Total Liabilities | 9.60 | 19.69 | 38.01 |
| Cash Flows (₹ Crores) | FY23 | FY24 | FY25 |
| Net Cash Generated From / (used in) Operating Activities | 23.85 | 3.44 | 8.72 |
| Net Cash Generated From / (used in) Investing Activities | -15.63 | -5.40 | -15.17 |
| Net Cash Generated From / (used in) Financing Activities | 5.25 | -1.24 | 1.82 |
| Net Increase (Decrease) in Cash and Cash Equivalents | 13.48 | -3.20 | -4.64 |
Strengths
1. Rising infertility expanding long-term patient demand.
2. Advanced technologies improving outcomes and success.
3. Strong potential for global fertility tourism.
4. Scalable hub-and-spoke expansion across cities.
Weaknesses
1. High capital requirements for advanced labs.
2. Regulatory inconsistencies across different states.
3. Social stigma in non-metro regions persists.
4. Dependence on specialist doctor availability.
Opportunities
1. Rapidly growing Indian IVF market size.
2. Insurance inclusion may boost affordability.
3. Expansion into Tier-II and Tier-III cities.
4. Rising demand for fertility preservation.
Threats
1. Potential tightening of ART regulations.
2. Economic slowdowns affecting discretionary spending.
3. Intensifying competition from hospital chains.
4. Increased ethical and legal scrutiny.
1. Strong presence in growing IVF market.
2. Scalable hub-and-spoke expansion strategy.
3. Diversified domestic and international patient base.
4. Comprehensive fertility and women’s healthcare services.
Gaudium IVF operates within India’s rapidly expanding fertility market, driven by rising infertility rates, delayed parenthood and increasing awareness of assisted reproductive technologies. With a scalable hub-and-spoke model, presence across major cities and growing international patient inflow, the company is well positioned to capture demand from Tier-II and Tier-III markets. Advancing technology adoption and comprehensive women’s healthcare integration further strengthen its long-term growth potential.
- Companies
- Type
- Opening On
- Sotefin Bharat
- SME
- 16th Jul
- Pre-Book
-
Caliber Mining
- Mainboard
- 17th Jul
- Pre-Book
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Gaudium IVF IPO opens from February 20, 2026 to February 24, 2026.
The size of Gaudium IVF IPO is ₹165.00 Cr.
The price band of Gaudium IVF IPO is fixed at ₹75 to ₹79.
To apply for Gaudium IVF IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Gaudium IVF. IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Gaudium IVF IPO is of 189 shares and the investment required is ₹14,175.
The share allotment date of Gaudium IVF IPO is February 25, 2026
The Gaudium IVF IPO will likely be listed on February 27, 2026.
Sarthi Capital Advisors Pvt.Ltd is the book running lead managers for Gaudium IVF IPO.
Gaudium IVF IPO plans to utilise the raised capital from the IPO for:
1) The Company will fund new IVF centres (₹50.00 crore).
2) Repayment or prepayment of outstanding loans (₹20.00 crore).
3) Allocation towards general corporate purposes (₹70.00 crore total).